ఇంటర్నేషనల్ ఆన్‌లైన్ మ

పేపర్లు ప్రచురించబడ్డాయి

సమీక్షా వ్యాసం

The Role of Autonomic Dysregulation from Pathophysiology to Therapeutics of Multiple Sclerosis: A Putative Novel Treatment Target?

Juan Manuel Racosta and Marcelo Kremenchutzky

Autonomic Nervous System (ANS) dysfunction (AuD) is a common cause of disability in people living with
Multiple Sclerosis (MS), but clinical manifestations are heterogene..మరిన్ని చూడండి»

నైరూప్య

Pharmacovigilance 2019:Loranthus Europaeus is a Nano Alternative Medicine in Treatment of symptom of Chemotherapy of Breast Cancer.

Ali Awad Hamoud Aljeboory1 & Nazhat Mahmood Abdlkareem Al-zubaidi

Disease is liable for one of every eight passings overall more than AIDS, tuberculosis, and jungle fever together. Common item despite everything keep on being significant as we..మరిన్ని చూడండి»

నైరూప్య

DEVELOPMENTS, CONCERNS AND ETHICAL CONSIDERATIONS OF AI (ARTIFICIAL INTELLIGENCE) IN MEDICINE

Imran Aslan

మరిన్ని చూడండి»

పరిశోధన వ్యాసం

Gene Expression Profiling and Bioinformatic Analysis of Rabbit Basilar Artery after Experimental Subarachnoid Hemorrhage

Yuichiro Kikkawa, Satoshi Matsuo, Masaaki Hokama, Ryota Kurogi, Akira Nakamizo, Masahiro Mizoguchi and Tomio Sasaki

Objective: The molecular mechanisms which contribute to the development of vascular events including cerebral
vasospasm after subarachnoid hemorrhage (SAH) in cerebral ar..మరిన్ని చూడండి»

దృష్టికోణం

The Socially Extended Market Institutions Approach to Economic Reasoning

Aayla Birrani*

An active and interactive interpretation of market and economic thinking through the concept of cognitive institutions. We contest conventional wisdom that views markets as eith..మరిన్ని చూడండి»

పరిశోధన వ్యాసం

Natalizumab to Fingolimod Switching in Multiple Sclerosis: Results from a “Real Word” Retrospective Analysis

Sarah Rasia, Cinzia Cordioli, Nicola De Rossi, Fabiana Pimazzoni, Cristina Scarpazza, Luisa Imberti and Ruggero Capra

Fingolimod is an alternative for patients with multiple sclerosis who discontinue natalizumab because of leukoencephalopathy risk. However, the interruption of natalizumab might..మరిన్ని చూడండి»

సంగ్రహించబడింది/ఇండెక్స్ చేయబడింది